VanEck Pharmaceutical Valuation
| PPH Etf | USD 86.25 0.33 0.38% |
At this time, the etf appears to be fairly valued. VanEck Pharmaceutical ETF has a current Real Value of $86.36 per share. The regular price of the etf is $86.25. Our model measures the value of VanEck Pharmaceutical ETF from inspecting the etf fundamentals such as Number Of Employees of 8, price to earning of 17.83 X, and Market Capitalization of 877.34 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that VanEck Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of VanEck Pharmaceutical ETF is based on 3 months time horizon. Increasing VanEck Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since VanEck Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VanEck Etf. However, VanEck Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 86.25 | Real 86.36 | Hype 86.25 | Naive 87.73 |
The intrinsic value of VanEck Pharmaceutical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence VanEck Pharmaceutical's stock price.
Estimating the potential upside or downside of VanEck Pharmaceutical ETF helps investors to forecast how VanEck etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VanEck Pharmaceutical more accurately as focusing exclusively on VanEck Pharmaceutical's fundamentals will not take into account other important factors: VanEck Pharmaceutical Total Value Analysis
VanEck Pharmaceutical ETF is at this time projected to have company total value of 877.34 M with market capitalization of 877.34 M, debt of , and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the VanEck Pharmaceutical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
877.34 M | 877.34 M |
VanEck Pharmaceutical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of VanEck signifies not a very effective usage of assets in July.About VanEck Pharmaceutical Valuation
An absolute valuation paradigm, as applied to VanEck Etf, attempts to find the value of VanEck Pharmaceutical ETF based on its fundamental and basic technical indicators. By analyzing VanEck Pharmaceutical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of VanEck Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of VanEck Pharmaceutical. We calculate exposure to VanEck Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VanEck Pharmaceutical's related companies. When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.